Guidelines for Economic Evaluations in Italy : Recommendations from the Italian Group of Pharmacoeconomic Studies

@inproceedings{Capri2001GuidelinesFE,
  title={Guidelines for Economic Evaluations in Italy : Recommendations from the Italian Group of Pharmacoeconomic Studies},
  author={Stefano Capri},
  year={2001}
}
Since 1997, in order for a new drug to obtain its price and reimbursement in Italy, the negotiation between authorities and the pharmaceutical industry must include an economic evaluation. The economic evaluation study leads to price and reimbursement negotiations together with such other requirements as the price of the new drug in other countries, the impact on the domestic market in terms of public pharmaceutical expenditure, and the effects on the national economy (employment and… CONTINUE READING

From This Paper

Topics from this paper.
39 Citations
27 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 39 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

Discounting and health tive audit of economic submissions to BMJ and the Lancet

  • M Parsonage, H. Neuburger
  • 1998

Discounting of life - saving and nomic evaluation : a review of published studies

  • EB Keeler, S Cretin
  • Health Econ
  • 1998

Guidelines for So - unavoidable necessity for the new drugs

  • A Alban, H Keiding, J Søgaard
  • On cioeconomic Analyses of Pharmaceuticals…
  • 1998

, and C / E ratios alongside a clinical trial

  • MA Koopmanschap, Rutten FFH, BM Ineveldvan
  • Health Econ
  • 1997

Consensus Conference . Statistical Principles for Clinical Trials . Geneva , Switzerland : ICH ; Janu - mation

  • BA vanHout, MJ Al, GS Gordon
  • Costs , effectsary
  • 1997

Guidelines and zation of models, great attention has to be Recommendations for French Pharmaco-economic paid to the methods applied, but they are an studies. CES

  • 1997

InModelling in economic evaluation : an avoidable fact of life

  • BJ O’Brien, MF Drummond, RJ Labelle
  • Health Econ
  • 1997

On the discounting of gained life - healthcare . Reinventing the wheel ? Pharmacoecon .

  • M Johannesson
  • 1997

Sensitivity analysis in eco - effectiveness analysis

  • A Briggs, M Sculpher
  • Some reflections on cost -
  • 1997

Similar Papers

Loading similar papers…